Evidence map›Paper›PMID 33234178›Full record

ArticleEpidemiology and infection2020

The transmissibility of hepatitis C virus: a modelling study in Xiamen City, China.

Yao Wang, Zeyu Zhao, Mingzhai Wang, Mikah Ngwanguong Hannah, Qingqing Hu, Jia Rui, Xingchun Liu, Yuanzhao Zhu, Jingwen Xu, Meng Yang and 4 more

Abstract read
In one paragraph

Article in Epidemiology and infection, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. ComputingInfectious Disease Modelling · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yao WangState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen361102, People's Republic of China.
Zeyu ZhaoState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen361102, People's Republic of China.
Mingzhai WangXiamen Center for Disease Control and Prevention, Xiamen361021, People's Republic of China.
Mikah Ngwanguong HannahMedical College, Xiamen University, Xiamen City, Fujian Province, People's Republic of China.ORCID 0000-0002-1494-7700
Qingqing HuDivision of Public Health, School of Medicine, University of Utah, 201 Presidents Circle, Salt Lake City, UT84112, USA.
Jia RuiState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen361102, People's Republic of China.
Xingchun LiuState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen361102, People's Republic of China.
Yuanzhao ZhuState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen361102, People's Republic of China.
Jingwen XuState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen361102, People's Republic of China.
Meng YangState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen361102, People's Republic of China.
Jing-An CuiDepartment of Mathematics, School of Science, Beijing University of Civil Engineering and Architecture, Beijing, People's Republic of China.
Yanhua SuState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen361102, People's Republic of China.
Benhua ZhaoState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen361102, People's Republic of China.
Tianmu ChenState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen361102, People's Republic of China.ORCID 0000-0003-0710-5086

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed at estimating the transmissibility of hepatitis C. The data for hepatitis C cases were collected in six districts in Xiamen City, China from 2004 to 2018. A population-mixed susceptible-infectious-chronic-recovered (SICR) model was used to fit the data and the parameters of the model were calculated. The basic reproduction number (R0) and the number of newly transmitted cases by a primary case per month (MNI) were adopted to quantitatively assess the transmissibility of hepatitis C virus (HCV). Eleven curve estimation models were employed to predict the trends of R0 and MNI in the city. The SICR model fits the reported HCV data well (P < 0.01). The median R0 of each district in Xiamen is 0.4059. R0 follows the cubic model curve, the compound curve and the power function curve. The median MNI of each district in Xiamen is 0.0020. MNI follows the cubic model curve, the compound curve and the power function curve. The transmissibility of HCV follows a decreasing trend, which reveals that under the current policy for prevention and control, there would be a high feasibility to eliminate the transmission of HCV in the city.

Indexed as

Models, BiologicalBasic Reproduction NumberChinaFemaleHepacivirusHepatitis CHumansMaleRetrospective StudiesHepatitis Cmathematical modeltransmissibilitytrend

Identifiers

PMID33234178
PMCPMC7770378

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.